Global Enoxaparin Sodium APIs and Preparations Market Research Report 2023

The global Enoxaparin Sodium APIs and Preparations market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Enoxaparin Sodium APIs and Preparations is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Enoxaparin Sodium APIs and Preparations is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Enoxaparin Sodium APIs and Preparations include Shandong Haike Chemical Group Co., Ltd, Manus Aktteva Biopharma LLP, Chemi SPA, Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Venus Remedies Ltd, JoinHub Pharma, Memphis Vision Care, Shenzhen Techdow Pharmaceutical Co., Ltd. and Hebei Changshan Biochemical Pharmaceutical Co. Ltd., etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium APIs and Preparations, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin Sodium APIs and Preparations.

The Enoxaparin Sodium APIs and Preparations market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Enoxaparin Sodium APIs and Preparations market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Enoxaparin Sodium APIs and Preparations manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Enoxaparin Sodium APIs and Preparations

1.2 Enoxaparin Sodium APIs and Preparations Segment by Type

1.2.1 Global Enoxaparin Sodium APIs and Preparations Market Value Comparison by Type (2023-2029)

1.2.2 20 mg/0.2mL

1.2.3 40 mg/0.4mL

1.2.4 60 mg/0.6mL

1.2.5 80 mg/0.8mL

1.2.6 100 mg/1mL

1.2.7 120 mg/0.8mL

1.2.8 150 mg/1mL

1.2.9 300mg/3mL

1.3 Enoxaparin Sodium APIs and Preparations Segment by Application

1.3.1 Global Enoxaparin Sodium APIs and Preparations Market Value by Application: (2023-2029)

1.3.2 Deep Vein Thrombosis

1.3.3 Pulmonary Embolism

1.3.4 Others

1.4 Global Enoxaparin Sodium APIs and Preparations Market Size Estimates and Forecasts

1.4.1 Global Enoxaparin Sodium APIs and Preparations Revenue 2018-2029

1.4.2 Global Enoxaparin Sodium APIs and Preparations Sales 2018-2029

1.4.3 Global Enoxaparin Sodium APIs and Preparations Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Enoxaparin Sodium APIs and Preparations Sales Market Share by Manufacturers (2018-2023)

2.2 Global Enoxaparin Sodium APIs and Preparations Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Enoxaparin Sodium APIs and Preparations Average Price by Manufacturers (2018-2023)

2.4 Global Enoxaparin Sodium APIs and Preparations Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Enoxaparin Sodium APIs and Preparations, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Enoxaparin Sodium APIs and Preparations, Product Type & Application

2.7 Enoxaparin Sodium APIs and Preparations Market Competitive Situation and Trends

2.7.1 Enoxaparin Sodium APIs and Preparations Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Enoxaparin Sodium APIs and Preparations Players Market Share by Revenue

2.7.3 Global Enoxaparin Sodium APIs and Preparations Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Enoxaparin Sodium APIs and Preparations Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Enoxaparin Sodium APIs and Preparations Global Enoxaparin Sodium APIs and Preparations Sales by Region: 2018-2029

3.2.1 Global Enoxaparin Sodium APIs and Preparations Sales by Region: 2018-2023

3.2.2 Global Enoxaparin Sodium APIs and Preparations Sales by Region: 2024-2029

3.3 Global Enoxaparin Sodium APIs and Preparations Global Enoxaparin Sodium APIs and Preparations Revenue by Region: 2018-2029

3.3.1 Global Enoxaparin Sodium APIs and Preparations Revenue by Region: 2018-2023

3.3.2 Global Enoxaparin Sodium APIs and Preparations Revenue by Region: 2024-2029

3.4 North America Enoxaparin Sodium APIs and Preparations Market Facts & Figures by Country

3.4.1 North America Enoxaparin Sodium APIs and Preparations Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Enoxaparin Sodium APIs and Preparations Sales by Country (2018-2029)

3.4.3 North America Enoxaparin Sodium APIs and Preparations Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Enoxaparin Sodium APIs and Preparations Market Facts & Figures by Country

3.5.1 Europe Enoxaparin Sodium APIs and Preparations Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Enoxaparin Sodium APIs and Preparations Sales by Country (2018-2029)

3.5.3 Europe Enoxaparin Sodium APIs and Preparations Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Enoxaparin Sodium APIs and Preparations Market Facts & Figures by Country

3.6.1 Asia Pacific Enoxaparin Sodium APIs and Preparations Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Enoxaparin Sodium APIs and Preparations Sales by Country (2018-2029)

3.6.3 Asia Pacific Enoxaparin Sodium APIs and Preparations Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Enoxaparin Sodium APIs and Preparations Market Facts & Figures by Country

3.7.1 Latin America Enoxaparin Sodium APIs and Preparations Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Enoxaparin Sodium APIs and Preparations Sales by Country (2018-2029)

3.7.3 Latin America Enoxaparin Sodium APIs and Preparations Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Enoxaparin Sodium APIs and Preparations Market Facts & Figures by Country

3.8.1 Middle East and Africa Enoxaparin Sodium APIs and Preparations Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Enoxaparin Sodium APIs and Preparations Sales by Country (2018-2029)

3.8.3 Middle East and Africa Enoxaparin Sodium APIs and Preparations Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Enoxaparin Sodium APIs and Preparations Sales by Type (2018-2029)

4.1.1 Global Enoxaparin Sodium APIs and Preparations Sales by Type (2018-2023)

4.1.2 Global Enoxaparin Sodium APIs and Preparations Sales by Type (2024-2029)

4.1.3 Global Enoxaparin Sodium APIs and Preparations Sales Market Share by Type (2018-2029)

4.2 Global Enoxaparin Sodium APIs and Preparations Revenue by Type (2018-2029)

4.2.1 Global Enoxaparin Sodium APIs and Preparations Revenue by Type (2018-2023)

4.2.2 Global Enoxaparin Sodium APIs and Preparations Revenue by Type (2024-2029)

4.2.3 Global Enoxaparin Sodium APIs and Preparations Revenue Market Share by Type (2018-2029)

4.3 Global Enoxaparin Sodium APIs and Preparations Price by Type (2018-2029)

5.1 Global Enoxaparin Sodium APIs and Preparations Sales by Application (2018-2029)

5.1.1 Global Enoxaparin Sodium APIs and Preparations Sales by Application (2018-2023)

5.1.2 Global Enoxaparin Sodium APIs and Preparations Sales by Application (2024-2029)

5.1.3 Global Enoxaparin Sodium APIs and Preparations Sales Market Share by Application (2018-2029)

5.2 Global Enoxaparin Sodium APIs and Preparations Revenue by Application (2018-2029)

5.2.1 Global Enoxaparin Sodium APIs and Preparations Revenue by Application (2018-2023)

5.2.2 Global Enoxaparin Sodium APIs and Preparations Revenue by Application (2024-2029)

5.2.3 Global Enoxaparin Sodium APIs and Preparations Revenue Market Share by Application (2018-2029)

5.3 Global Enoxaparin Sodium APIs and Preparations Price by Application (2018-2029)

6.1 Shandong Haike Chemical Group Co., Ltd

6.1.1 Shandong Haike Chemical Group Co., Ltd Corporation Information

6.1.2 Shandong Haike Chemical Group Co., Ltd Description and Business Overview

6.1.3 Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Product Portfolio

6.1.5 Shandong Haike Chemical Group Co., Ltd Recent Developments/Updates

6.2 Manus Aktteva Biopharma LLP

6.2.1 Manus Aktteva Biopharma LLP Corporation Information

6.2.2 Manus Aktteva Biopharma LLP Description and Business Overview

6.2.3 Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Product Portfolio

6.2.5 Manus Aktteva Biopharma LLP Recent Developments/Updates

6.3 Chemi SPA

6.3.1 Chemi SPA Corporation Information

6.3.2 Chemi SPA Description and Business Overview

6.3.3 Chemi SPA Enoxaparin Sodium APIs and Preparations Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Chemi SPA Enoxaparin Sodium APIs and Preparations Product Portfolio

6.3.5 Chemi SPA Recent Developments/Updates

6.4 Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

6.4.1 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Corporation Information

6.4.2 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Description and Business Overview

6.4.3 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Product Portfolio

6.4.5 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Recent Developments/Updates

6.5 Venus Remedies Ltd

6.5.1 Venus Remedies Ltd Corporation Information

6.5.2 Venus Remedies Ltd Description and Business Overview

6.5.3 Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Product Portfolio

6.5.5 Venus Remedies Ltd Recent Developments/Updates

6.6 JoinHub Pharma

6.6.1 JoinHub Pharma Corporation Information

6.6.2 JoinHub Pharma Description and Business Overview

6.6.3 JoinHub Pharma Enoxaparin Sodium APIs and Preparations Sales, Revenue and Gross Margin (2018-2023)

6.6.4 JoinHub Pharma Enoxaparin Sodium APIs and Preparations Product Portfolio

6.6.5 JoinHub Pharma Recent Developments/Updates

6.7 Memphis Vision Care

6.6.1 Memphis Vision Care Corporation Information

6.6.2 Memphis Vision Care Description and Business Overview

6.6.3 Memphis Vision Care Enoxaparin Sodium APIs and Preparations Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Memphis Vision Care Enoxaparin Sodium APIs and Preparations Product Portfolio

6.7.5 Memphis Vision Care Recent Developments/Updates

6.8 Shenzhen Techdow Pharmaceutical Co., Ltd.

6.8.1 Shenzhen Techdow Pharmaceutical Co., Ltd. Corporation Information

6.8.2 Shenzhen Techdow Pharmaceutical Co., Ltd. Description and Business Overview

6.8.3 Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Product Portfolio

6.8.5 Shenzhen Techdow Pharmaceutical Co., Ltd. Recent Developments/Updates

6.9 Hebei Changshan Biochemical Pharmaceutical Co. Ltd.

6.9.1 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Corporation Information

6.9.2 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Description and Business Overview

6.9.3 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Product Portfolio

6.9.5 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Recent Developments/Updates

6.10 Meithal Pharmaceuticals

6.10.1 Meithal Pharmaceuticals Corporation Information

6.10.2 Meithal Pharmaceuticals Description and Business Overview

6.10.3 Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Product Portfolio

6.10.5 Meithal Pharmaceuticals Recent Developments/Updates

6.11 Gland Pharma

6.11.1 Gland Pharma Corporation Information

6.11.2 Gland Pharma Enoxaparin Sodium APIs and Preparations Description and Business Overview

6.11.3 Gland Pharma Enoxaparin Sodium APIs and Preparations Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Gland Pharma Enoxaparin Sodium APIs and Preparations Product Portfolio

6.11.5 Gland Pharma Recent Developments/Updates

6.12 Dongying Tiandong Pharmaceutical Co., Ltd.

6.12.1 Dongying Tiandong Pharmaceutical Co., Ltd. Corporation Information

6.12.2 Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Description and Business Overview

6.12.3 Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Product Portfolio

6.12.5 Dongying Tiandong Pharmaceutical Co., Ltd. Recent Developments/Updates

7.1 Enoxaparin Sodium APIs and Preparations Industry Chain Analysis

7.2 Enoxaparin Sodium APIs and Preparations Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Enoxaparin Sodium APIs and Preparations Production Mode & Process

7.4 Enoxaparin Sodium APIs and Preparations Sales and Marketing

7.4.1 Enoxaparin Sodium APIs and Preparations Sales Channels

7.4.2 Enoxaparin Sodium APIs and Preparations Distributors

7.5 Enoxaparin Sodium APIs and Preparations Customers

8.1 Enoxaparin Sodium APIs and Preparations Industry Trends

8.2 Enoxaparin Sodium APIs and Preparations Market Drivers

8.3 Enoxaparin Sodium APIs and Preparations Market Challenges

8.4 Enoxaparin Sodium APIs and Preparations Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Enoxaparin Sodium APIs and Preparations Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Enoxaparin Sodium APIs and Preparations Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Enoxaparin Sodium APIs and Preparations Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Enoxaparin Sodium APIs and Preparations Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Enoxaparin Sodium APIs and Preparations Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Enoxaparin Sodium APIs and Preparations Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Enoxaparin Sodium APIs and Preparations Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Enoxaparin Sodium APIs and Preparations Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Enoxaparin Sodium APIs and Preparations, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Enoxaparin Sodium APIs and Preparations, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Enoxaparin Sodium APIs and Preparations, Product Type & Application

    Table 12. Global Key Manufacturers of Enoxaparin Sodium APIs and Preparations, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Enoxaparin Sodium APIs and Preparations by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enoxaparin Sodium APIs and Preparations as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Enoxaparin Sodium APIs and Preparations Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Enoxaparin Sodium APIs and Preparations Sales by Region (2018-2023) & (K Units)

    Table 18. Global Enoxaparin Sodium APIs and Preparations Sales Market Share by Region (2018-2023)

    Table 19. Global Enoxaparin Sodium APIs and Preparations Sales by Region (2024-2029) & (K Units)

    Table 20. Global Enoxaparin Sodium APIs and Preparations Sales Market Share by Region (2024-2029)

    Table 21. Global Enoxaparin Sodium APIs and Preparations Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Enoxaparin Sodium APIs and Preparations Revenue Market Share by Region (2018-2023)

    Table 23. Global Enoxaparin Sodium APIs and Preparations Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Enoxaparin Sodium APIs and Preparations Revenue Market Share by Region (2024-2029)

    Table 25. North America Enoxaparin Sodium APIs and Preparations Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Enoxaparin Sodium APIs and Preparations Sales by Country (2018-2023) & (K Units)

    Table 27. North America Enoxaparin Sodium APIs and Preparations Sales by Country (2024-2029) & (K Units)

    Table 28. North America Enoxaparin Sodium APIs and Preparations Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Enoxaparin Sodium APIs and Preparations Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Enoxaparin Sodium APIs and Preparations Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Enoxaparin Sodium APIs and Preparations Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Enoxaparin Sodium APIs and Preparations Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Enoxaparin Sodium APIs and Preparations Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Enoxaparin Sodium APIs and Preparations Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Enoxaparin Sodium APIs and Preparations Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Enoxaparin Sodium APIs and Preparations Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Enoxaparin Sodium APIs and Preparations Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Enoxaparin Sodium APIs and Preparations Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Enoxaparin Sodium APIs and Preparations Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Enoxaparin Sodium APIs and Preparations Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Enoxaparin Sodium APIs and Preparations Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Enoxaparin Sodium APIs and Preparations Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Enoxaparin Sodium APIs and Preparations Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Enoxaparin Sodium APIs and Preparations Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Enoxaparin Sodium APIs and Preparations Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Enoxaparin Sodium APIs and Preparations Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Enoxaparin Sodium APIs and Preparations Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Enoxaparin Sodium APIs and Preparations Sales (K Units) by Type (2018-2023)

    Table 51. Global Enoxaparin Sodium APIs and Preparations Sales (K Units) by Type (2024-2029)

    Table 52. Global Enoxaparin Sodium APIs and Preparations Sales Market Share by Type (2018-2023)

    Table 53. Global Enoxaparin Sodium APIs and Preparations Sales Market Share by Type (2024-2029)

    Table 54. Global Enoxaparin Sodium APIs and Preparations Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Enoxaparin Sodium APIs and Preparations Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Enoxaparin Sodium APIs and Preparations Revenue Market Share by Type (2018-2023)

    Table 57. Global Enoxaparin Sodium APIs and Preparations Revenue Market Share by Type (2024-2029)

    Table 58. Global Enoxaparin Sodium APIs and Preparations Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Enoxaparin Sodium APIs and Preparations Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Enoxaparin Sodium APIs and Preparations Sales (K Units) by Application (2018-2023)

    Table 61. Global Enoxaparin Sodium APIs and Preparations Sales (K Units) by Application (2024-2029)

    Table 62. Global Enoxaparin Sodium APIs and Preparations Sales Market Share by Application (2018-2023)

    Table 63. Global Enoxaparin Sodium APIs and Preparations Sales Market Share by Application (2024-2029)

    Table 64. Global Enoxaparin Sodium APIs and Preparations Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Enoxaparin Sodium APIs and Preparations Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Enoxaparin Sodium APIs and Preparations Revenue Market Share by Application (2018-2023)

    Table 67. Global Enoxaparin Sodium APIs and Preparations Revenue Market Share by Application (2024-2029)

    Table 68. Global Enoxaparin Sodium APIs and Preparations Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Enoxaparin Sodium APIs and Preparations Price (US$/Unit) by Application (2024-2029)

    Table 70. Shandong Haike Chemical Group Co., Ltd Corporation Information

    Table 71. Shandong Haike Chemical Group Co., Ltd Description and Business Overview

    Table 72. Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Product

    Table 74. Shandong Haike Chemical Group Co., Ltd Recent Developments/Updates

    Table 75. Manus Aktteva Biopharma LLP Corporation Information

    Table 76. Manus Aktteva Biopharma LLP Description and Business Overview

    Table 77. Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Product

    Table 79. Manus Aktteva Biopharma LLP Recent Developments/Updates

    Table 80. Chemi SPA Corporation Information

    Table 81. Chemi SPA Description and Business Overview

    Table 82. Chemi SPA Enoxaparin Sodium APIs and Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Chemi SPA Enoxaparin Sodium APIs and Preparations Product

    Table 84. Chemi SPA Recent Developments/Updates

    Table 85. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Corporation Information

    Table 86. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Description and Business Overview

    Table 87. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Product

    Table 89. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Recent Developments/Updates

    Table 90. Venus Remedies Ltd Corporation Information

    Table 91. Venus Remedies Ltd Description and Business Overview

    Table 92. Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Product

    Table 94. Venus Remedies Ltd Recent Developments/Updates

    Table 95. JoinHub Pharma Corporation Information

    Table 96. JoinHub Pharma Description and Business Overview

    Table 97. JoinHub Pharma Enoxaparin Sodium APIs and Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. JoinHub Pharma Enoxaparin Sodium APIs and Preparations Product

    Table 99. JoinHub Pharma Recent Developments/Updates

    Table 100. Memphis Vision Care Corporation Information

    Table 101. Memphis Vision Care Description and Business Overview

    Table 102. Memphis Vision Care Enoxaparin Sodium APIs and Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. Memphis Vision Care Enoxaparin Sodium APIs and Preparations Product

    Table 104. Memphis Vision Care Recent Developments/Updates

    Table 105. Shenzhen Techdow Pharmaceutical Co., Ltd. Corporation Information

    Table 106. Shenzhen Techdow Pharmaceutical Co., Ltd. Description and Business Overview

    Table 107. Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 108. Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Product

    Table 109. Shenzhen Techdow Pharmaceutical Co., Ltd. Recent Developments/Updates

    Table 110. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Corporation Information

    Table 111. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Description and Business Overview

    Table 112. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 113. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Product

    Table 114. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Recent Developments/Updates

    Table 115. Meithal Pharmaceuticals Corporation Information

    Table 116. Meithal Pharmaceuticals Description and Business Overview

    Table 117. Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 118. Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Product

    Table 119. Meithal Pharmaceuticals Recent Developments/Updates

    Table 120. Gland Pharma Corporation Information

    Table 121. Gland Pharma Description and Business Overview

    Table 122. Gland Pharma Enoxaparin Sodium APIs and Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 123. Gland Pharma Enoxaparin Sodium APIs and Preparations Product

    Table 124. Gland Pharma Recent Developments/Updates

    Table 125. Dongying Tiandong Pharmaceutical Co., Ltd. Corporation Information

    Table 126. Dongying Tiandong Pharmaceutical Co., Ltd. Description and Business Overview

    Table 127. Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 128. Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Product

    Table 129. Dongying Tiandong Pharmaceutical Co., Ltd. Recent Developments/Updates

    Table 130. Key Raw Materials Lists

    Table 131. Raw Materials Key Suppliers Lists

    Table 132. Enoxaparin Sodium APIs and Preparations Distributors List

    Table 133. Enoxaparin Sodium APIs and Preparations Customers List

    Table 134. Enoxaparin Sodium APIs and Preparations Market Trends

    Table 135. Enoxaparin Sodium APIs and Preparations Market Drivers

    Table 136. Enoxaparin Sodium APIs and Preparations Market Challenges

    Table 137. Enoxaparin Sodium APIs and Preparations Market Restraints

    Table 138. Research Programs/Design for This Report

    Table 139. Key Data Information from Secondary Sources

    Table 140. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Enoxaparin Sodium APIs and Preparations

    Figure 2. Global Enoxaparin Sodium APIs and Preparations Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Enoxaparin Sodium APIs and Preparations Market Share by Type in 2022 & 2029

    Figure 4. 20 mg/0.2mL Product Picture

    Figure 5. 40 mg/0.4mL Product Picture

    Figure 6. 60 mg/0.6mL Product Picture

    Figure 7. 80 mg/0.8mL Product Picture

    Figure 8. 100 mg/1mL Product Picture

    Figure 9. 120 mg/0.8mL Product Picture

    Figure 10. 150 mg/1mL Product Picture

    Figure 11. 300mg/3mL Product Picture

    Figure 12. Global Enoxaparin Sodium APIs and Preparations Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 13. Global Enoxaparin Sodium APIs and Preparations Market Share by Application in 2022 & 2029

    Figure 14. Deep Vein Thrombosis

    Figure 15. Pulmonary Embolism

    Figure 16. Others

    Figure 17. Global Enoxaparin Sodium APIs and Preparations Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Enoxaparin Sodium APIs and Preparations Market Size (2018-2029) & (US$ Million)

    Figure 19. Global Enoxaparin Sodium APIs and Preparations Sales (2018-2029) & (K Units)

    Figure 20. Global Enoxaparin Sodium APIs and Preparations Average Price (US$/Unit) & (2018-2029)

    Figure 21. Enoxaparin Sodium APIs and Preparations Report Years Considered

    Figure 22. Enoxaparin Sodium APIs and Preparations Sales Share by Manufacturers in 2022

    Figure 23. Global Enoxaparin Sodium APIs and Preparations Revenue Share by Manufacturers in 2022

    Figure 24. The Global 5 and 10 Largest Enoxaparin Sodium APIs and Preparations Players: Market Share by Revenue in 2022

    Figure 25. Enoxaparin Sodium APIs and Preparations Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 26. Global Enoxaparin Sodium APIs and Preparations Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 27. North America Enoxaparin Sodium APIs and Preparations Sales Market Share by Country (2018-2029)

    Figure 28. North America Enoxaparin Sodium APIs and Preparations Revenue Market Share by Country (2018-2029)

    Figure 29. United States Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Canada Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Europe Enoxaparin Sodium APIs and Preparations Sales Market Share by Country (2018-2029)

    Figure 32. Europe Enoxaparin Sodium APIs and Preparations Revenue Market Share by Country (2018-2029)

    Figure 33. Germany Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. France Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. U.K. Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Italy Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Russia Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Asia Pacific Enoxaparin Sodium APIs and Preparations Sales Market Share by Region (2018-2029)

    Figure 39. Asia Pacific Enoxaparin Sodium APIs and Preparations Revenue Market Share by Region (2018-2029)

    Figure 40. China Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Japan Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. South Korea Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. India Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Australia Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. China Taiwan Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Southeast Asia Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Latin America Enoxaparin Sodium APIs and Preparations Sales Market Share by Country (2018-2029)

    Figure 48. Latin America Enoxaparin Sodium APIs and Preparations Revenue Market Share by Country (2018-2029)

    Figure 49. Mexico Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Brazil Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Argentina Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Market Share by Country (2018-2029)

    Figure 53. Middle East & Africa Enoxaparin Sodium APIs and Preparations Revenue Market Share by Country (2018-2029)

    Figure 54. Turkey Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Saudi Arabia Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 56. UAE Enoxaparin Sodium APIs and Preparations Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 57. Global Sales Market Share of Enoxaparin Sodium APIs and Preparations by Type (2018-2029)

    Figure 58. Global Revenue Market Share of Enoxaparin Sodium APIs and Preparations by Type (2018-2029)

    Figure 59. Global Enoxaparin Sodium APIs and Preparations Price (US$/Unit) by Type (2018-2029)

    Figure 60. Global Sales Market Share of Enoxaparin Sodium APIs and Preparations by Application (2018-2029)

    Figure 61. Global Revenue Market Share of Enoxaparin Sodium APIs and Preparations by Application (2018-2029)

    Figure 62. Global Enoxaparin Sodium APIs and Preparations Price (US$/Unit) by Application (2018-2029)

    Figure 63. Enoxaparin Sodium APIs and Preparations Value Chain

    Figure 64. Enoxaparin Sodium APIs and Preparations Production Process

    Figure 65. Channels of Distribution (Direct Vs Distribution)

    Figure 66. Distributors Profiles

    Figure 67. Bottom-up and Top-down Approaches for This Report

    Figure 68. Data Triangulation

    Figure 69. Key Executives Interviewed